Bybit Launches Regeneron Pharmaceuticals (REGN) Perpetual Contracts with Up to 20x Leverage
Bybit, a leading cryptocurrency exchange, has announced the launch of Regeneron Pharmaceuticals (REGN) perpetual contracts. Trading for these contracts is now open, with leverage of up to 20x available. REGN is the ticker symbol for Regeneron Pharmaceuticals, a U.S. biopharmaceutical company.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Bybit公告 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
FXBK Coin Analysis: What Is It? Is It Worth Investing In?
-
2
Bitcoin rises above $77,000, bucking tech selloff driven by AI safety concerns and rising oil prices
-
3
Taiwan to open second quasi-diplomatic mission in the Philippines, sources say
-
4
Cosco Shipping Heavy Industry Completes China IPO Guidance Registration
-
5
Xi Pitches AI Vision as Silicon Valley Leaders Tap Brakes
-
6
Samsung Display develops world's first 6.9-inch mobile OLED panel with 2K resolution, 165Hz refresh rate, and 30% lower power consumption
-
7
ATPAD (AtomPad) Project Status Analysis: An Inactive Cryptocurrency
-
8
INX Token Trading Guide: Distinguishing Infinex and INX Limited Tokens and Trading Platforms
-
9
GLIDE Coin Analysis: Project Status and Market Liquidity Analysis
-
10
AntiMatter (MATTER) Token Analysis: Trading, Buying, and Market Status
Markets Today
Recommended Reading







